Molecular Partners AG American Depositary Shares

Go to Molecular Partners AG American Depositary Shares Website

$3.94

0.29 (7.95%)
Live
Previous Close

$3.94

Day Range

$3.6 - $3.94

Previous Day Range

$3.65 - $3.65

Market Cap

$134.6 million USD

Day Vol.

381

Previous Day Vol.

675

Currency

USD

Primary Exchange

Nasdaq

Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeuti...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Molecular Partners reported positive data from an ongoing Phase 1/2a trial of its tetraspecific T-cell engager MP0533 in relapsed/refractory acute myeloid leukemia (AML). The data showed a 30% response rate in the latest cohort, with one patient maintaining a response beyond 6 months. The company plans to further optimize the dosing regimen to maximize the therapeutic benefit of MP0533.

Related tickers: MOLN.

Read Full Article

Molecular Partners announced progress in its Radio-DARPin pipeline, including plans to submit an IND for MP0712 targeting DLL3 in H1 2025 and ongoing Phase 1/2a trial for MP0533. The company also expanded its partnership with Orano Med and provided financial updates.

Related tickers: MOLN.

Read Full Article
Trending Tickers

Please sign in to view